Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme

Published 2016 View Full Article

Authors

Keywords

Glioblastoma multiforme, Dual antisense oligonucleotide-dual antibody nanobioconjugate, Blood-brain barrier delivery, Protein kinase CK2, EGFR/EGFRvIII

Journal

JOURNAL OF CONTROLLED RELEASE

Volume 244, Issue -, Pages 14-23

Publisher

Elsevier BV

Online

2016-11-05

DOI

10.1016/j.jconrel.2016.11.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now